NOW APPROVED  
Signifor(R) LAR (pasireotide) for injectable suspension 20mg, 40mg, 60mg
SIGNIFOR LAR is coming soon in early 2015.
 
 
FULL PRESCRIBING
INFORMATION
  CONTACT A
SALES SPECIALIST
 
 
 
 
If you prefer not to receive any future promotional e-mail communications about SIGNIFOR LAR from Novartis Pharmaceuticals Corporation, please click here.
 
If you would prefer not to receive any future promotional e-mail communications from Novartis Pharmaceuticals Corporation, please click here.


 
 
 
 
NOVARTIS
   
 
Signifor[R] LAR
 
   
Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080

   
 
© 2014 Novartis
 
 

12/14

SIA-1106139
 
 
 
 
This is a sponsored message from DMD on behalf of Novartis Pharmaceuticals Corporation & Novartis Group of Companies. DMD provides sponsored health care related messages from trusted third parties. The following material is intended specifically and exclusively for US Health Care Professionals. You are receiving this email because you have subscribed and agreed to receive information from the DMD email list.
 
If you prefer to not receive further information from this sender, please click here and confirm your request.
 
DMD
10255 W. Higgins Road, Suite 280
Rosemont, IL 60018